glp 1 glp Who Should Explore GLP-1 Shots from BodyLogicMD? have resource to make it easier than ever. The Rise of GLP-1 Medications
Description
doi: 10.1530/EC-17-0294 228 ZhangDMaMLiuY
J.et al
In 2015, the SCALE study demonstrated that the GLP-1 analogue Liraglutide (3.0 mg weekly) results in 8.0% body weight loss [49], and a mean HbA1c reduction of 1.1% [50] after 56 weeks
By week 6, approximately 70% of users report complete resolution of nausea symptoms
1).51 Moreover, a series of clinical trials suggest that the GLP-1 receptor agonists could induce cardiovascular protection.5255 Pleiotropic effect of GLP-1 receptor agonists
10.1161/CIRCRESAHA.121.319874 [DOI] [PMC free article] [PubMed] [Google Scholar] 24
